Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Seropositive umbilical cord blood transplant (UCBT) recipients are at increased risk for CMV complications. To reduce CMV complications, we adopted an intensive strategy that consisted of ganciclovir administered before transplantation (5 mg/kg intravenously daily from day −8 to day −2), high-dose a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Milano, Filippo, Pergam, Steven A., Xie, Hu, Leisenring, Wendy M., Gutman, Jonathan A., Riffkin, Ivy, Chow, Victor, Boeckh, Michael J., Delaney, Colleen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2011
Aiheet:
Clinical Trials and Observations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217367/
https://ncbi.nlm.nih.gov/pubmed/21937692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-361618
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia